The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Comparison of buprenorphine and methadone in the treatment of opioid dependence
Abstract
OBJECTIVE: This study compared the efficacy of buprenorphine and methadone in the treatment of opioid dependence. METHOD: Participants (N = 164) were relatively treatment-naive, opioid-dependent applicants to a 26-week treatment program who were randomly assigned to either methadone or buprenorphine treatment. Dosing was double-blind and double-dummy. Patients were stabilized on a regimen of either methadone, 50 mg, or buprenorphine, 8 mg, with dose changes possible through week 16 of treatment. Urine samples were collected three times a week, and weekly counseling was provided. RESULTS: Buprenorphine (mean dose = 8.9 mg/day) and methadone (mean dose = 54 mg/day) were equally effective in sustaining retention in treatment, compliance with medication, and counseling regimens. In both groups, 56% of patients remained in treatment through the 16-week flexible dosing period. Overall opioid-positive urine sample rates were 55% and 47% for buprenorphine and methadone groups, respectively; cocaine-positive urine sample rates were 70% and 58%. Evidence was obtained for the effectiveness of dose increases in suppressing opioid, but not cocaine, use among those who received dose increases. CONCLUSIONS: The results of this study provide further support for the utility of buprenorphine as a new medication in the treatment of opioid dependence and demonstrate efficacy equivalent to that of methadone when used during a clinically guided flexible dosing procedure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240
Jasinski, D. R. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770280111012 · Cited by 782
A Controlled Trial of Buprenorphine Treatment for Opioid Dependence
Johnson, R. E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480200058024 · Cited by 572
Buprenorphine versus Methadone Maintenance for Opioid Dependence
KOSTEN, T. R., SCHOTTENFELD, R., ZIEDONIS, D., & FALCIONI, J. (1993) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199306000-00004 · Cited by 267
A clinical trial of buprenorphine: Comparison with methadone in the detoxification of heroin addicts
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.13 · Cited by 260
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
Bickel, W. K., Stitzer, M. L., Bigelow, G. E., Liebson, I. A., Jasinski, D. R., & Johnson, R. E. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20047-7 · Cited by 226
Dose-Response Effects of Methadone in the Treatment of Opioid Dependence
Strain, E. C., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-1-199307010-00004 · Cited by 224
Methadone Maintenance Treatment
Senay, E. C. (1985) · International Journal of the Addictions · doi:10.3109/10826088509047754 · Cited by 173
Buprenorphine Suppresses Cocaine Self-Administration by Rhesus Monkeys
Mello, N. K., Mendelson, J. H., Bree, M. P., & Lukas, S. E. (1989) · Science · doi:10.1126/science.2772637 · Cited by 165
Buprenorphine effects on human heroin self-administration: an operant analysis.
Mello, N. K., Mendelson, J. H., & Kuehnle, J. C. (1982) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33287-8 · Cited by 157
Cited by
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Understanding polydrug use: review of heroin and cocaine co‐use
Leri, F., Bruneau, J., & Stewart, J. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00236.x · Cited by 790
Connock, M., Juarez-Garcia, A., Jowett, S., Frew, E., Liu, Z., Taylor, R., Fry-Smith, A., Day, E., Lintzeris, N., Roberts, T., et al. (2007) · Health Technology Assessment · doi:10.3310/hta11090 · Cited by 585
Amato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence
Uchtenhagen, A. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-17408 · Cited by 490
Kakko, J., Svanborg, K. D., Kreek, M. J., & Heilig, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12600-1 · Cited by 466
Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., Wesson, D. R., Mcnicholas, L., Tusel, D. J., Malkerneker, U., et al. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9344753.x · Cited by 402
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R., Kimber, J., Breen, C., & Davoli, M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub2 · Cited by 360
Comer, S. D., Sullivan, M. A., Yu, E., Rothenberg, J. L., Kleber, H. D., Kampman, K., Dackis, C., & O’Brien, C. P. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.210 · Cited by 348
Buprenorphine: Clinical Pharmacokinetics in the Treatment of Opioid Dependence
Elkader, A., & Sproule, B. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544070-00001 · Cited by 335
Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“, 2005) (Ib) found that methadone at an average dose of 80 mg was superior to buprenorphine average dose 15 mg, whereas two studies showed no difference between the two treatments in opioid or cocaine-free urines at 26 weeks (Strain et al., 1994) and 24 weeks (Schottenfeld et al.”
BackgroundPain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent
Compton, P., Charuvastra, V. C., & Ling, W. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00200-3 · Cited by 311
Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse
Schottenfeld, R. S. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830200041006 · Cited by 303
Jones, H. E., Johnson, R. E., Jasinski, D. R., O’Grady, K. E., Chisholm, C. A., Choo, R. E., Crocetti, M., Dudas, R., Harrow, C., Huestis, M. A., et al. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.11.013 · Cited by 295
Mattick, R. P., Ali, R., White, J. M., O'Brien, S., Wolk, S., & Danz, C. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00335.x · Cited by 285
Human Pharmacokinetics of Intravenous, Sublingual, and Buccal Buprenorphine
Kuhlman, J. J., Lalani, S., Magluilo, J., Levine, B., Darwin, W. D., Johnson, R. E., & Cone, E. J. (1996) · Journal of Analytical Toxicology · doi:10.1093/jat/20.6.369 · Cited by 273
Lofwall, M. R., Walsh, S. L., Nunes, E. V., Bailey, G. L., Sigmon, S. C., Kampman, K. M., Frost, M., Tiberg, F., Linden, M., Sheldon, B., et al. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2018.1052 · Cited by 255
O’Connor, P., Oliveto, A., Shi, J., Triffleman, E., Carroll, K., Kosten, T., Rounsaville, B., Pakes, J., & Schottenfeld, R. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00194-6 · Cited by 174
Clinical efficacy of buprenorphine: comparisons to methadone and placebo
LING, W. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00059-0 · Cited by 121
Buprenorphine tapering schedule and illicit opioid use
Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., Jenkins, J., Hasson, A., Annon, J., Saxon, A., et al. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02455.x · Cited by 112
BRIDGE, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00061-9 · Cited by 63
Ahmadi, J., Ahmadi, K., & Ohaeri, J. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01218.x · Cited by 58
Heroin anticraving medications: a systematic review
Fareed, A., Vayalapalli, S., Casarella, J., Amar, R., & Drexler, K. (2010) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2010.505991 · Cited by 41
Vignau, J., Duhamel, A., Catteau, J., Legal, G., Huynh, A., Grailles, I., Beauvillain, J., Petit, P., Beauvillain, P., & Parquet, P. J. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00189-1 · Cited by 39
Dissemination of Contingency Management for the Treatment of Opioid Use Disorder
DeFulio, A. (2023) · Perspectives on Behavior Science · doi:10.1007/s40614-022-00328-z · Cited by 28
“Medications such as methadone and buprenorphine (Suboxone®) are effective in promoting abstinence from illicit opioids and preventing drug overdose (Sordo et al., 2017; Strain et al., 1994).”
BackgroundOffice-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis
King, J. B., Sainski-Nguyen, A. M., & Bellows, B. K. (2016) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2015.1135847 · Cited by 20
Buprenorphine for Opioid Detoxification: A Brief Review
Kosten, T. R. (2003) · Addictive Disorders & Their Treatment · doi:10.1097/00132576-200302040-00001 · Cited by 8
Strain, E. C., Preston, K. L., Stitzer, M. L., Liebson, I. A., & Bigelow, G. E. (1994) · The American Journal on Addictions · doi:10.1111/j.1521-0391.1994.tb00380.x · Cited by 4
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1994-07-01
- Volume
- 151
- Issue
- 7
- Pages
- 1025-1030
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W125827253
- Cited by
- 305
- References
- 15
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.